Cutaneous Manifestation of Paroxysmal Nocturnal Hemoglobinuria

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare acquired genetic defect of the hematopoietic stem cell characterized by a triad of hemolytic anemia, pancytopenia, and thrombosis. Cutaneous thrombosis is a rare manifestation of this disease. Herein, we report a case of a patient with PNH whose first and only symptom was localized severe cutaneous thrombosis with hemorrhagic necrosis. During the diagnostic workup, it was necessary to exclude possible causes of chronic hemolysis without anemia and also to perform the confirmatory genetic test. The patient was discharged anticoagulated and with a recommendation for oral corticosteroids at weaning until initiating targeted therapy with eculizumab. To date, only 15 cases of PNH-associated cutaneous thrombosis have been documented worldwide. This paper focuses on highlighting and describing a rare manifestation of this disease and reviewing the existing literature.

Authors

Institutions

Publication Details

Journal
Medicina Interna
Published
2026-11-16
DOI
https://doi.org/10.24950/rspmi.2778
Primary Topic
Complement system in diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Cutaneous Manifestation of Paroxysmal Nocturnal Hemoglobinuria

Elisa Caldeira, Catarina Nóbrega, Teresa da Silva
Medicina Interna
Complement system in diseases
article

Cutaneous Manifestation of Paroxysmal Nocturnal Hemoglobinuria

Elisa Caldeira, Catarina Nóbrega, Teresa da Silva
article en

Abstract

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare acquired genetic defect of the hematopoietic stem cell characterized by a triad of hemolytic anemia, pancytopenia, and thrombosis. Cutaneous thrombosis is a rare manifestation of this disease. Herein, we report a case of a patient with PNH whose first and only symptom was localized severe cutaneous thrombosis with hemorrhagic necrosis. During the diagnostic workup, it was necessary to exclude possible causes of chronic hemolysis without anemia and also to perform the confirmatory genetic test. The patient was discharged anticoagulated and with a recommendation for oral corticosteroids at weaning until initiating targeted therapy with eculizumab. To date, only 15 cases of PNH-associated cutaneous thrombosis have been documented worldwide. This paper focuses on highlighting and describing a rare manifestation of this disease and reviewing the existing literature.

Medicina Interna
Hospital Dr. Nélio Mendonça (PT)
Complement system in diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon